Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Mallinckrodt to divest its contrast media business to Guerbet

July 29, 2015

Azedra receives breakthrough therapy designation for pheochromocytoma and paraganglioma

July 29, 2015

Grant supports development of Minomic's antibody technology

July 29, 2015

Lilly divulges several analyses of phase III solanezumab trial data

July 27, 2015

Roche Diagnostics launches HTLV blood test

July 23, 2015

Gadovist approved for use in pediatric patients in E.U.

July 15, 2015

Progenics Pharmaceuticals to conduct phase III trial of 1404

July 8, 2015

Celtic Biotech and Emory University agree to develop crotamine-based imaging agent

July 7, 2015

[18F]AZC2, a novel PET probe for c-MET imaging

July 7, 2015

First-in-human clear images of glioblastoma patients using [18F]AA-7

July 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...